Multichannel Excellence Europe

Customizing adds the magic! Is Pharma making headway?

The study  sheds light on the “Magic” of Multichannel Excellence. The paper provides you with insights into the vast possibilities Multichannel Excellence offers and uncovers to what extent Pharma already knows of them. The paper further explores Pharma´s status quo of MCEx and outlines what obstacles keep companies from realizing MCEx´s full potential. The reader will also learn about Camelot´s comprehensive understanding of Multichannel Excellence and receive valuable insights how to make headway adopting this integrated concept. Taylor Wessing´s deep level of legal expertise in the pharmaceutical sector has added to this comprehensive analysis of Multichannel Excellence. There are no uncontrollable legal risks relating to MCEx, but there are many options to make MCEx work. This paper is designed to pave the way for MCEx to be rolled out across the European markets.

Request Free Download

Our studies provide carefully prepared, valuable insights, which we are happy to share with you free of charge. We just ask you for a short registration.

By entering my data, I hereby declare that I agree and permit CAMELOT Management Consultants AG to contact me about the topic "Multichannel Excellence Europe"

In addition, I agree that my data may be used by CAMELOT Management Consultants AG and associated companies to inform me about service offerings, events, studies, or further activities. The user may revoke his declaration of consent at any time. In this case, please use the following link: https://www.camelot-mc.com/en/privacy-policy.